Literature DB >> 20232394

Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.

Min Wang1, Juan Xiao, Min Shen, Yu Yahong, Rui Tian, Feng Zhu, Jianxin Jiang, Zhiyong Du, Jun Hu, Wensong Liu, Renyi Qin.   

Abstract

Recent studies suggest that the ability to form and grow tumors specifically resides in a small cell population called cancer stem cells (CSCs). These studies were conducted mainly on various human cancers; however, isolation and characterization of stem cells from cholangiocarcinoma have not been attempted. The molecular markers CD24, CD44, CD34, and epithelial cell adhesion molecule (EpCAM) are widely used, individually or in combination, to characterize some types of CSCs. In this study, we used these markers to identify a subpopulation of cells in extrahepatic cholangiocarcinoma (ECC) with cancer stem/progenitor cell-like properties. We found that CD24(+) CD44(+) EpCAM(high) cells (0.39-2.27%) were present in human ECC tissues. The expression of a CD24(+) CD44(+) EpCAM(high) subpopulation was consistent with primary cancers and could be duplicated during serial in vivo passaging in NOD/SCID mice. CD24(+) CD44(+) EpCAM(high) cells isolated from 3 cholangiocarcinoma xenografts showed high tumorigenic potential compared with CD24(-) CD44(-) EpCAM(low/-) cells. These tumorigenic ECC cells exhibited the stem cell properties of self-renewal and ability to produce heterogeneous progeny. We report the identification of a CSC population in ECC characterized by CD24, CD44 and EpCAM phenotypes. Our findings could provide new insight into the tumorigenesis of cholangiocarcinoma and offer a potential target for anti-cancer therapy.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20232394     DOI: 10.1002/ijc.25317

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Effect of resveratrol and oxyresveratrol on deferoxamine-induced cancer stem cell marker expression in human head and neck squamous cell carcinoma.

Authors:  Artid Amorntaveechai; Thanaphum Osathanon; Prasit Pavasant; Sireerat Sooampon
Journal:  J Oral Biol Craniofac Res       Date:  2022-03-16

Review 2.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

3.  B7-H3 targeted antibody-based immunotherapy of malignant diseases.

Authors:  Theodoros Michelakos; Filippos Kontos; Omar Barakat; Luke Maggs; Joseph H Schwab; Cristina R Ferrone; Soldano Ferrone
Journal:  Expert Opin Biol Ther       Date:  2020-12-21       Impact factor: 4.388

4.  The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.

Authors:  Christian Mayr; Andrej Wagner; Daniel Neureiter; Martin Pichler; Martin Jakab; Romana Illig; Frieder Berr; Tobias Kiesslich
Journal:  BMC Complement Altern Med       Date:  2015-06-23       Impact factor: 3.659

5.  The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.

Authors:  Christian Mayr; Andrej Wagner; Magdalena Loeffelberger; Daniela Bruckner; Martin Jakab; Frieder Berr; Pietro Di Fazio; Matthias Ocker; Daniel Neureiter; Martin Pichler; Tobias Kiesslich
Journal:  Oncotarget       Date:  2016-01-05

6.  CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma.

Authors:  Vishnu Modur; Pooja Joshi; Daotai Nie; K Thomas Robbins; Aziz U Khan; Krishna Rao
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

7.  BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.

Authors:  Shinsuke Nakashima; Shogo Kobayashi; Hiroaki Nagano; Akira Tomokuni; Yoshito Tomimaru; Tadafumi Asaoka; Naoki Hama; Hiroshi Wada; Koichi Kawamoto; Shigeru Marubashi; Hidetoshi Eguchi; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2015-04-22       Impact factor: 6.716

8.  Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis.

Authors:  Joshua A Harrill; Bethany B Parks; Eliane Wauthier; J Craig Rowlands; Lola M Reid; Russell S Thomas
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 9.  Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis.

Authors:  Rani Ojha; Shalmoli Bhattacharyya; Shrawan K Singh
Journal:  Biores Open Access       Date:  2015-01-01

10.  Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.

Authors:  F Peng; J Jiang; Y Yu; R Tian; X Guo; X Li; M Shen; M Xu; F Zhu; C Shi; J Hu; M Wang; R Qin
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.